Statements (112)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Company
|
| gptkbp:acquisition |
gptkb:Zymergen
gptkb:Grail,_Inc. gptkb:Edico_Genome gptkb:GRAIL,_Inc. gptkb:Solexa gptkb:Verily_Life_Sciences gptkb:Base_Space_Sequence_Hub gptkb:Grail gptkb:Illumina_Clinical_Services_Lab gptkb:Illumina_Genomics gptkb:Illumina_Instruments gptkb:Illumina_Platforms gptkb:Illumina_Software gptkb:Illumina_Technologies gptkb:Illumina_Ventures gptkb:Next_Seq Illumina Sequencing Blue Bee Verinata Health Illumina Applications Illumina Bioinformatics Illumina Collaborations Illumina Community Engagement Illumina Consumables Illumina Corporate Social Responsibility Illumina Customer Support Illumina Distribution Illumina Education Illumina Innovations Illumina Investments Illumina Manufacturing Illumina Marketing Illumina Outreach Illumina Partnerships Illumina Research Illumina Research and Development Illumina Sales Illumina Services Illumina Solutions Illumina Sustainability Illumina Training |
| gptkbp:ceo |
gptkb:Francis_de_Souza
|
| gptkbp:employees |
over 7,000
|
| gptkbp:focus |
gptkb:collaboration
gptkb:software_framework gptkb:Cloud_Computing_Service gptkb:computer community engagement data analysis regulatory compliance clinical trials data sharing genetic testing personalized medicine quality control research funding bioinformatics educational outreach collaborative research variant calling biobanking clinical validation RNA sequencing gene expression analysis transcriptomics metagenomics epigenomics cancer genomics genetic variation analysis clinical genomics innovation in genomics pharmaceutical genomics agricultural genomics population genomics single-cell genomics microbiome research exome sequencing whole-genome sequencing targeted resequencing genomic data privacy open-source genomics |
| gptkbp:founded |
gptkb:1998
|
| gptkbp:founder |
gptkb:Jay_Flatley
|
| gptkbp:headquarters |
gptkb:San_Diego,_California,_USA
gptkb:San_Diego,_California |
| https://www.w3.org/2000/01/rdf-schema#label |
Illumina
|
| gptkbp:industry |
genomics
|
| gptkbp:market |
genomic analysis
|
| gptkbp:market_cap |
over $40 billion (2021)
|
| gptkbp:partnership |
gptkb:temple
gptkb:Bristol-Myers_Squibb gptkb:Pfizer gptkb:Merck_&_Co. gptkb:Roche gptkb:Amgen gptkb:GRAIL,_Inc. gptkb:Illumina_Accelerator gptkb:Novartis with various research institutions |
| gptkbp:products |
DNA sequencing systems
genomic analysis tools |
| gptkbp:revenue |
over $3 billion (2020)
$3.24 billion (2020) |
| gptkbp:services |
genomic sequencing
|
| gptkbp:symbol |
gptkb:ILMN
|
| gptkbp:technology |
next-generation sequencing
|
| gptkbp:bfsParent |
gptkb:Company
gptkb:Roche gptkb:National_Park gptkb:municipality |
| gptkbp:bfsLayer |
3
|